Approach [spco]
Drug Therapy [topp]
Diabetes Mellitus, Type 2 [dsyn]
New Agents [clas]
Pharmacological [bmod]
Recently [tmco]
Management [ocac]
Type 2 [clas]
Diabetes Mellitus, Non-Insulin-Dependent [dsyn]
Article [inpr]
Various [irda]
therapeutic agents [inpr]
Available [ftcn]
Management [ocac]
Patients [podg]
Diabetes Mellitus, Type 2 [dsyn]
Suggest [idcn]
Approach [spco]
Drug [phsu]
General [spco]
Therapeutic [topp]
modalities [idcn]
Relevant [qlco]
Diabetes [dsyn]
Care [acty]
Modality [idcn]
Life Style [socb]
Adjustments [inbe]
Improving [qlco]
Endogenous [ftcn]
Insulin Sensitivity [patf]
Insulin [aapp, horm, phsu]
increased activity [fndg]
Physical [hlca]
Body Weight [orga]
reduction [npop]
Diet [food]
Behavioral Modification [topp]
Pharmacologic Agent [phsu]
Surgery [bmod]
Modality [idcn]
Depth [spco]
Article [inpr]
Second [qnco]
Modality [idcn]
increasing insulin [dsyn]
Availability [ftcn]
Administration [ocac]
Exogenous [spco]
Insulin [aapp, horm, phsu]
Insulin Analogue [aapp, horm, phsu]
sulphonylureas [orch, phsu]
Insulin [aapp, horm, phsu]
repaglinide [orch, phsu]
Frequently [tmco]
encounter [hlca]
Adverse Effect [fndg]
Agent [chvf]
Hypoglycaemia [dsyn]
Body Weight Gain [fndg]
Concern [idcn]
Patients [podg]
Obese [dsyn]
Association [menp]
Hyperinsulinaemia [dsyn]
Premature [tmco]
Atherosclerosis [dsyn]
Question [inpr]
Modality [idcn]
Agent [chvf]
Biguanides [orch, phsu]
Thiazolidinediones [orch, phsu]
Enhance [acty]
Insulin Sensitivity [patf]
Agent [chvf]
Decrease [qlco]
Insulin [aapp, horm, phsu]
Requirement [ftcn]
Alpha Glucosidase Inhibitors [phsu]
Diabetes Mellitus, Type 2 [dsyn]
Heterogeneous [qlco]
Multiple [qnco]
pathophysiology [ftcn]
Process [bpoc]
therapy [ftcn]
Based [ftcn]
Degree [qlco]
Hyperglycaemia [dsyn]
Hyperinsulinaemia [dsyn]
Insulin [aapp, horm, phsu]
Deficiency [ftcn]
Addition [ftcn]
Several [qnco]
considered [idcn]
prescribing [hlca]
Specific [qlco]
Therapeutic agent [inpr]
Efficacy [qlco]
Safety [hcpp]
affordability [qnco]
Ease [menp]
Administration [ocac]
